Thursday 27 February, 2020

17:00-18:30 Registries on glomerular diseases
Chairpersons: Theophanis Apostolou, Marten Segelmark
    Biopsy registries, Marten Segelmark
    IgA nephropathy: Data from the Registry of Hellenic Society of Nephrology, Marios Papasotiriou
    Membranous nephropathy: Data from the Registry of Hellenic Society of Nephrology, Maria Stangou
18:30-19:00 Focal segmental glomerulosclerosis
Chairpersons:  Dimitrios Goumenos, Vasilios Liakopoulos

Differentiating primary, genetic and secondary FSGS, Fernando Fervenza
19:15-20:45 IgA nephropathy
Chairpersons: Dimitrios Goumenos, Rosanna Coppo

    A detective control of complement regulation in IgA nephropathy, Rosana Coppo
    Novel treatment for IgA nephropathy: the case for complement inhibition, Annette Bruchfeld
    How to assess the risk of progression of IgA nephropathy, Rosana Coppo

Friday 28 February, 2020

8:30-9:30 C3, Interstitial nephritis
Chairpersons: Evangelos Papachristou, Gema Fernandez

    Update on C3 glomerulopathy, Kultigin Turkmen
    Treatment of acute tubulointerstitial nephritis, Gema Fernandez
9:30-11:00 Membranous nephropathy /Monoclonal gammopathies
Chairpersons: Aikaterini Papagianni, Fernando Fervenza

    New antigens in membranous nephropathy, Sanjeev Sethi
    Monoclonal gammopathy-associated renal diseases, Sanjeev Sethi
    Membranous nephropathy – what have we learned from MENTOR?, Fernando Fervenza
11:15-12:45 Vasculitides
Chairpersons: Ploumis Passadakis, Rodrigo Cartin-Ceba

    Differences in epidemiology, prognosis and treatment of ANCA associated vasculitis, Rodrigo Cartin-Ceba
    Kidney involvement in ANCA associated vasculitis, Sophia Lionaki
    The role of complement in ANCA Associated Vasculitis (AAV), Vladimir Tesar
12:45-13:45 Thrombotic microangiopathies / hemodialysis
Chairpersons: Stylianos Panagoutsos, Kultigin Turkmen

    Atypical Hemolytic Uremic Syndrome (aHUS), Vladimir Tesar
    Infectious complications of dialysis, An De Vriese
15:45-17:15 Other glomerular diseases
Chairpersons: Elias Thodis, Dario Roccatello

    An update on Anti-GBM disease, Marten Segelmark
    HCV-associated glomerulonephritis/vasculitis: current treatment considerations in the era of direct antiviral drugs, Annette Bruchfeld
    Treatment of cryoglobulinemic nephritis, Dario Roccatello
17:15-18:45 Kidney transplantation
Chairpersons: Ioannis N. Boletis, Annette Bruchfeld

    Practical guide to interpreting donor specific antibodytesting in the current era, Carrie Schinstock
    Making sense of the varied presentations of antibody mediated rejection in the renal allograft, Carrie Schinstock
    Ischemia and reperfusion injury in transplantation, Cees van Kooten

Saturday 29 February, 2020

8:30-10:30 Polycystic kidney disease
Chairpersons: Eugenios Dafnis, Fouad Chebib

    Prognostication in ADPKD, Fouad Chebib
    Clinical implications of genetic testing in ADPKD patients, Emile Cornec Le Gall
    The role of genetic modifiers and molecular interactions in ARPKD diagnosis and prognosis, Paraskevi Goggolidou
    Advances in management of patients with ADPKD, Fouad Chebib
10:45-12:15 Lupus nephritis
Chairpersons: Ioannis N. Boletis, Vladimir Tesar

    New insights in the pathogenesis of lupus nephritis, Eleni Frangou
    New treatment strategies in lupus nephritis, Ladan Zand
    New avenues in lupus nephritis (clinical lecture), Hans Joachim Anders
12:15-13:45 Monoclonal gammopathie / Membranous nephropathy
Chairpersons: Dimitrios Vlachakos, Ladan Zand

    Reappraisal of AntiPLA2R antibodies in serum and kidney tissue of patients with membranous nephropathy, Dimitrios Goumenos
    Cast nephropathy, Vladimir Tesar
    Monoclonal gammopathy of renal significance: whento do renal biopsy and how to treat?, Ladan Zand
16:00-17:15 Chronic kidney disease
Chairpersons: Ioannis Stefanidis, Antonello Pani

    Prevalence of CKD and its relationship to eGFR-related genetic loci and clinical risk factors in a general population (the SardiNIA study cohort), Antonello Pani
    The role of hypertension, proteinuria and dietary protein consumption in the progression of kidney disease, Pantelis Sarafidis
    Kidney size in relation to ageing, gender, renal function, birthweight and chronic kidney disease risk factors ina general population (Aging Kidney), Antonello Pani
17:30-19:00 Pregnancy and kidney
Chairpersons: Aikaterini Papagianni, Andrea Kattah

    Preeclampsia: Update on pathogenesis and long-term implications, Andrea Kattah
    Pregnancy in women with glomerulonephritis, Kapsia Eleni
    Effects of pregnancy on the transplanted kidney, Andrea Kattah
19:00-20:00 Perspectives for novel therapies
Chairpersons: Ploumis Passadakis, Hans Joachim Anders

    Targeting podocytes beyond standard-of-care, Hans Joachim Anders
    Antifibrotic therapies: where and why in human kidney disease, Dimitrios Goumenos